Medical devices, healthcare technology and the business of care
PMA approval · P250008

Claire OCT System

Perimeter Medical Imaging Ai, Inc. · Decision date Mar 3, 2026

FDA DECISIONP250008

What did the FDA approve?

FDA records P250008 as an original PMA application. The recorded decision is approval, dated Mar 3, 2026.

FDA approval order statement

The Claire OCT System is an adjunctive three-dimensional imaging tool which provides volumetric cross-sectional, real-time depth visualization, coupled with an artificial intelligence computer-aided detection algorithm which identifies and marks focal areas suspicious for breast cancer and is used concurrently with physician interpretation of the images. The Claire OCT System is intended for use in conjunction with other standard methods for evaluation of the margins of excised lumpectomy tissue during surgical procedures in patients with a biopsy-confirmed diagnosis of breast cancer.
Regulatory pathway
Original PMA
Clinical specialty
General, Plastic Surgery
Decision date
Mar 3, 2026

FDA source record

Regulatory record facts

Identifier
P250008
Regulatory pathway
Premarket approval application
Product code
SHH
Decision code
APPR
Decision date
Mar 3, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: OCT imaging system with AI/ML software for adjunctive detection of breast cancer.

Product code
SHH
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P250008 received

    Application receipt date recorded by FDA.

  2. P250008 · FDA decision

    APPR

Timeline entries are records held by MedtechLedger for P250008. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P250008

Product / regulatory recordCompanyPathwayDecision dateSource
Claire OCT SystemP250008/S001
Perimeter Medical Imaging Ai, Inc.PMA supplementAug 10, 2026FDA

Explore the linked device profile

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Perimeter Medical Imaging Ai, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
555 Richmond St. W, Suite 511, Toronto, M5V 3B1

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records